Background Parkinson's disease has been identified as a risk factor for severe Coronavirus
disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death …

Abstract Background Parkinson's Disease (PD) is among one of the common comorbidities
in older patients. People with PD may be more vulnerable to severe pneumonia, due to the …

Introduction Specific pre-existing medical conditions (eg hypertension or obesity), advanced
age and male sex appear linked to more severe manifestations of SARS Co-V2 infection …

The global explosion of COVID-19 necessitated the rapid dissemination of information
regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's …

Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid‐19)
had a decline in motor functions; nevertheless, there is limited evidence on whether PD …

Background The indirect impact of the COVID-19 epidemic on major clinical outcomes of
people with Parkinson's disease (PD) or other parkinsonism is unknown. Objectives The …

Background: Many studies on Parkinson's disease (PD) patients affected by Coronavirus-
disease-2019 (COVID-19) were recently published. However, the small sample size of …

Background and purpose The patterns of long‐term risk of SARS‐CoV‐2 infection,
hospitalization for COVID‐19, and related death are uncertain in people with Parkinson …

Background The clinical, neuropsychological, and socioeconomic factors affecting
Parkinson's disease (PD) during COVID‐19 pandemic across different populations have not …

The COVID-19 outbreak has had a dramatic impact on the healthcare system due to the
rapid, worldwide spread of the virus, highlighting several considerations on the best …